22 completed, 9 unknown, 3 recruiting, 1 not yet recruiting. 35 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 35 | Completed 22, Unknown 9, Recruiting 3, Not yet recruiting 1 |
Follow Ischemic Heart Disease: new trials by email Literature Review of Ischemic Heart Disease trials Research Report on Ischemic Heart Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease Continuation of daily low-dose Aspirin, Discontinuation of daily low-dose Aspirin - Ischemic Heart Disease, Ischemic Heart Disease Chronic | Phase 4 | Recruiting | Odense University Hospital | 7000 | 2026-09-30 | 2026-10-05 |
| Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses Adenosine - Chronic Coronary Syndrome, Coronary Artery Disease | Phase 4 | Recruiting | Region Skane | 180 | 2024-10-23 | 2026-08-13 |
| Continuity of Care Between Primary Care Cardiology and Specialty Services for Patients With Chronic Ischemic Heart Disease Inclisiran - Ischemic Heart Disease, Acute Coronary Syndrome | Phase 4 | Not yet recruiting | Jose Seijas Amigo | 50 | 2024-06-01 | 2024-05-20 |
| Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization Aspirin, No aspirin - Stable Angina Pectoris, Coronary Artery Disease | Phase 4 | Recruiting | Takeshi Morimoto | 2890 | 2022-06-14 | 2025-03-11 |
| One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease Aspirin, Atorvastatin, Perindopril - Ischemic Heart Disease | Phase 4 | Unknown | University of Roma La Sapienza | 100 | 2019-11-01 | 2019-11-05 |
| Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease Allopurinol - Diabetes Mellitus, Ischemic Heart Disease | Phase 4 | Unknown | Tel-Aviv Sourasky Medical Center | 100 | 2018-12-01 | 2018-11-21 |
| Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation Aspirin + clopidogrel, Clopidogrel monotherapy, Aspirin monotherapy - Gastrointestinal Injury, Ischemic Heart Disease | Phase 4 | Completed | Shenyang Northern Hospital | 783 | 2017-07-13 | 2022-05-19 |
| Randomized Anticoagulation Trial in Opcab (RATIO) Heparin - Ischemic Heart Disease | Phase 4 | Unknown | Azienda Ospedaliera di Lecco | 900 | 2017-01-01 | 2017-05-12 |
| Does the Advice to Eat a Mediterranean Diet With Low Carbohydrate Intake, Compared With a Low-fat Diet, Reduce Diabetes and Cardiovascular Disease? Advice on what food to choose and eat - Ischemic Heart Disease | Phase 4 | Unknown | University Hospital, Linkoeping | 1200 | 2016-10-01 | 2019-04-24 |
| Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor vildagliptin, Dapagliflozin - Diabetes Mellitus, Type 2, Ischemic Heart Disease | Phase 4 | Completed | Chiang Mai University | 43 | 2014-10-01 | 2018-07-19 |
| Ranolazine for Improving Symptoms of Palpitations Ranolazine, Placebo - Ischemic Heart Disease | Phase 4 | Unknown | University of Roma La Sapienza | 100 | 2014-01-01 | 2013-03-07 |
| Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson Regadenoson - Ischemic Heart Disease | Phase 4 | Completed | Washington University School of Medicine | 16 | 2013-01-01 | 2018-06-15 |
| Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease Metformin plus vildagliptin, Metformin only - Type 2 Diabetes Mellitus, Ischemic Heart Disease | Phase 4 | Completed | Sheba Medical Center | 60 | 2012-09-01 | 2016-04-19 |
| The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting Biomatrix drug eluting stent - Ischemic Heart Disease | Phase 4 | Unknown | Zealand University Hospital | 5100 | 2012-03-01 | 2012-02-16 |
| The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial Metformin, Placebo - Cardiovascular Disease, Ischemic Heart Disease | Phase 4 | Completed | Radboud University Medical Center | 100 | 2011-11-01 | 2014-07-29 |
| Effects of N-acetylcysteine on Low T3 Syndrome N-acetylcysteine - Acute Myocardial Infarction, Euthyroid Sick Syndrome | Phase 4 | Completed | Federal University of Rio Grande do Sul | 83 | 2011-11-01 | 2015-03-31 |
| Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents 6-month dual anti-platelet therapy, 12-month dual anti-platelet therapy, Zotarolimus eluting stent - Ischemic Heart Disease | Phase 4 | Completed | Gangnam Severance Hospital | 1368 | 2011-05-02 | 2017-02-17 |
| Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease Amlodipine - Ischemic Heart Disease | Phase 4 | Completed | Ruttonjee Hospital | 97 | 2010-07-01 | 2012-06-06 |
| Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)? Dipyridamole, placebo - Cardiovascular Disease, Ischemic Heart Disease | Phase 4 | Completed | Radboud University Medical Center | 95 | 2009-12-01 | 2013-01-10 |
| PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems) Catheterization, stent deployment - Ischemic Heart Disease | Phase 4 | Completed | Medinol Ltd. | 278 | 2009-04-01 | 2018-03-27 |
Showing 20 of 35. Sign in to see all of them.
Myocardial Ischemia (35) · Acute Coronary Syndrome (3) · Cardiovascular Diseases (3) · Coronary Artery Disease (3) · Angina, Stable (2) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2) · Heart Failure (2) · Hypertension (2) · Myocardial Infarction (2) · Reperfusion Injury (2) · Stroke (2) · Acquired Immunodeficiency Syndrome (1) · Angina Pectoris (1) · Angina, Unstable (1)
Heart Diseases (35) · Vascular Diseases (35) · Cardiovascular Diseases (32) · Pathological Conditions, Signs and Symptoms (8) · Pathologic Processes (6) · Endocrine System Diseases (5) · Arterial Occlusive Diseases (4) · Arteriosclerosis (4) · Glucose Metabolism Disorders (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Chest Pain (3) · Coronary Disease (3) · Neurologic Manifestations (3) · Pain (3)
Aspirin (5) · Clopidogrel (3) · Atorvastatin (2) · Metformin (2) · Valsartan (2) · Vildagliptin (2) · ALN-PCS (1) · Acetylcysteine (1) · Adenosine (1) · Allopurinol (1) · Amlodipine (1) · Catheterization (1) · Celecoxib (1) · Cilostazol (1) · Coronary Artery Bypass (1)
Shenyang Northern Hospital (3) · Radboud University Medical Center (2) · University of Florida (2) · University of Roma La Sapienza (2) · Azienda Ospedaliera di Lecco (1) · BSP Biological Signal Processing Ltd. (1) · Chiang Mai University (1) · Copenhagen University Hospital, Rigshospitalet (1) · Federal University of Rio Grande do Sul (1) · Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy (1) · Gangnam Severance Hospital (1) · Jikei University School of Medicine (1) · Jose Seijas Amigo (1) · Kyoto Prefectural University of Medicine (1) · Medinol Ltd. (1)
China (5) · Denmark (4) · Italy (4) · Japan (4) · Netherlands (4) · Israel (3) · Sweden (3) · United States (3) · Germany (2) · Poland (2) · Spain (2) · Belgium (1) · Brazil (1) · Canada (1) · Finland (1)
Carl J Pepine, MD (2) · Yaling Han, M.D. (2) · Andrew YW Li, MB (1) · Andrzej Bochenek, Prof (1) · Arintaya Phrommintikul, MD (1) · Dan Tzivoni, Professor (1) · Danilo Neglia, MD, PhD (1) · Edoardo Camenzind, MD (1) · Finlay McAlister, MD,MSc (1) · Francesco Pelliccia, MD (1) · Fredrik H Nystrom, MD professor (1) · Giuseppe Marazzi (1) · Gunnar VH Jensen, MD (1)
PMID 10400006, PMID 12595860, PMID 15367828, PMID 16098418, PMID 17467513, PMID 19723695, PMID 19933787, PMID 21982660, PMID 22951082, PMID 23118347, PMID 24622709, PMID 24627416, PMID 24890531, PMID 25106761, PMID 25148231, PMID 25307535, PMID 25711274, PMID 25773594, PMID 25910523, PMID 26179504, PMID 28202051, PMID 28335893, PMID 28532406, PMID 31672148, PMID 32588238, PMID 34671067, PMID 37976067, PMID 8540450, PMID 9359541, PMID 9817489
2009 (1), 2023 (1), U01HL064924 (1)